199 related articles for article (PubMed ID: 34036168)
1. Clinical Implications of Tacrolimus Time in Therapeutic Range and Intrapatient Variability in Urban Renal Transplant Recipients Undergoing Early Corticosteroid Withdrawal.
Pierce DR; West-Thielke P; Hajjiri Z; Gaitonde S; Tzvetanov I; Benedetti E; Lichvar AB
Transplant Direct; 2021 Jun; 7(6):e698. PubMed ID: 34036168
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus Intrapatient Variability, Time in Therapeutic Range, and Risk of De Novo Donor-Specific Antibodies.
Davis S; Gralla J; Klem P; Stites E; Wiseman A; Cooper JE
Transplantation; 2020 Apr; 104(4):881-887. PubMed ID: 32224815
[TBL] [Abstract][Full Text] [Related]
3. Tacrolimus variability is associated with de novo donor-specific antibody development in pediatric renal transplant recipients.
Solomon S; Colovai A; Del Rio M; Hayde N
Pediatr Nephrol; 2020 Feb; 35(2):261-270. PubMed ID: 31732803
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus time in therapeutic range and long-term outcomes in heart transplant recipients.
Adie SK; Bitar A; Konerman MC; Dorsch MP; Andrews CA; Pogue K; Park JM
Pharmacotherapy; 2022 Feb; 42(2):106-111. PubMed ID: 34882822
[TBL] [Abstract][Full Text] [Related]
5. Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients.
Leino AD; Park JM; Pasternak AL
Pharmacotherapy; 2021 Aug; 41(8):649-657. PubMed ID: 34129685
[TBL] [Abstract][Full Text] [Related]
6. Tacrolimus time-in-therapeutic range is associated with freedom from acute rejection and graft failure following intestinal transplantation.
Santeusanio AD; Gu A; Weinberg AD; Moon J; Iyer KR
Clin Transplant; 2021 Jun; 35(6):e14291. PubMed ID: 33740822
[TBL] [Abstract][Full Text] [Related]
7. Within-Patient Variability in Tacrolimus Blood Levels Predicts Kidney Graft Loss and Donor-Specific Antibody Development.
Rodrigo E; Segundo DS; Fernández-Fresnedo G; López-Hoyos M; Benito A; Ruiz JC; de Cos MA; Arias M
Transplantation; 2016 Nov; 100(11):2479-2485. PubMed ID: 26703349
[TBL] [Abstract][Full Text] [Related]
8. Increasing Time in Therapeutic Range of Tacrolimus in the First Year Predicts Better Outcomes in Living-Donor Kidney Transplantation.
Song T; Yin S; Jiang Y; Huang Z; Liu J; Wang Z; Li L; Zeng J; Fan Y; Wang X; Li X; Lin T
Front Immunol; 2019; 10():2912. PubMed ID: 31921171
[No Abstract] [Full Text] [Related]
9. Increasing tacrolimus time-in-therapeutic range is associated with superior one-year outcomes in lung transplant recipients.
Ensor CR; Iasella CJ; Harrigan KM; Morrell MR; Moore CA; Shigemura N; Zeevi A; McDyer JF; Venkataramanan R
Am J Transplant; 2018 Jun; 18(6):1527-1533. PubMed ID: 29513387
[TBL] [Abstract][Full Text] [Related]
10. Impact of a pharmacist-led tacrolimus management protocol in the outpatient setting.
Owen K; Winters H; Palettas M; Witkowsky O
J Am Pharm Assoc (2003); 2022; 62(6):1912-1918. PubMed ID: 35843802
[TBL] [Abstract][Full Text] [Related]
11. Intrapatient Variability in Tacrolimus Exposure Does Not Predict The Development of Cardiac Allograft Vasculopathy After Heart Transplant.
Shuker N; Bouamar R; Hesselink DA; van Gelder T; Caliskan K; Manintveld OC; Balk AH; Constantinescu AA
Exp Clin Transplant; 2018 Jun; 16(3):326-332. PubMed ID: 28969528
[TBL] [Abstract][Full Text] [Related]
12. Optimal blood levels of (extended-release) tacrolimus in living donor kidney transplantation to prevent de novo donor-specific antibody production: A retrospective cohort study.
Hiramitsu T; Tomosugi T; Futamura K; Okada M; Nishihira M; Goto N; Ichimori T; Narumi S; Kobayashi T; Uchida K; Watarai Y
Int Immunopharmacol; 2021 Feb; 91():107038. PubMed ID: 33388731
[TBL] [Abstract][Full Text] [Related]
13. Association between time in therapeutic range of tacrolimus blood concentration and acute rejection within the first three months after lung transplantation.
Katada Y; Nakagawa S; Itohara K; Suzuki T; Kato R; Endo H; Sugimoto M; Yonezawa A; Nakagawa T; Ohsumi A; Nakajima D; Date H; Terada T
J Pharm Health Care Sci; 2022 Oct; 8(1):25. PubMed ID: 36180948
[TBL] [Abstract][Full Text] [Related]
14. Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.
Theruvath TP; Saidman SL; Mauiyyedi S; Delmonico FL; Williams WW; Tolkoff-Rubin N; Collins AB; Colvin RB; Cosimi AB; Pascual M
Transplantation; 2001 Jul; 72(1):77-83. PubMed ID: 11468538
[TBL] [Abstract][Full Text] [Related]
15. Tacrolimus: a further update of its use in the management of organ transplantation.
Scott LJ; McKeage K; Keam SJ; Plosker GL
Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
[TBL] [Abstract][Full Text] [Related]
16. High tacrolimus intra-patient variability is associated with graft rejection, and
Del Bello A; Congy-Jolivet N; Danjoux M; Muscari F; Lavayssière L; Esposito L; Hebral AL; Bellière J; Kamar N
World J Gastroenterol; 2018 Apr; 24(16):1795-1802. PubMed ID: 29713132
[TBL] [Abstract][Full Text] [Related]
17. High Intrapatient Tacrolimus Variability Is Associated With Worse Outcomes in Renal Transplantation Using a Low-Dose Tacrolimus Immunosuppressive Regime.
Whalen HR; Glen JA; Harkins V; Stevens KK; Jardine AG; Geddes CC; Clancy MJ
Transplantation; 2017 Feb; 101(2):430-436. PubMed ID: 26950724
[TBL] [Abstract][Full Text] [Related]
18. Time to reach tacrolimus maximum blood concentration,mean residence time, and acute renal allograft rejection: an open-label, prospective, pharmacokinetic study in adult recipients.
Kuypers DR; Vanrenterghem Y
Clin Ther; 2004 Nov; 26(11):1834-44. PubMed ID: 15639695
[TBL] [Abstract][Full Text] [Related]
19. The Effect of Tacrolimus Trough Variability on Kidney Transplant Outcomes.
Heeney S; Szempruch KR; Lee RM; Mintz A; Serrano P; Detwiler R; Doligalski C
Transplant Proc; 2020 Dec; 52(10):3129-3133. PubMed ID: 32896383
[TBL] [Abstract][Full Text] [Related]
20. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
Considine A; Tredger JM; Heneghan M; Agarwal K; Samyn M; Heaton ND; O'Grady JG; Aluvihare VR
Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
